Quantcast

Johnson & Johnson


Recent News About Johnson & Johnson View More

SCOTUS decision changes everything in Missouri mass tort cases; Once-$72M verdict will stay vacated

By Karen Kidd | Mar 19, 2018

ST. LOUIS (Legal Newsline) – The Missouri Supreme Court's decision earlier this month to not review a talcum powder case against Johnson & Johnson, leaving vacated a once-$72 million verdict signals that the "Show-Me State is now a less tort-friendly place," a mass tort litigator says.

Johnson & Johnson, facing meso claim in New Jersey, points to plaintiff's childhood home, schools

By Glenn Minnis | Feb 7, 2018

NEW BRUNSWICK, N.J. (Legal Newsline) – Lawyers for a non-smoker who are alleging Johnson's Baby Powder created his mesothelioma will face a defense strategy that says the man's childhood home, as well as the schools he attended, could have caused the illness.

Pfizer sues Johnson & Johnson over alleged anti-competitive practices

By Jessica Karmasek | Oct 30, 2017

Pfizer’s lawsuit, filed in a Pennsylvania federal court in September, alleges Johnson & Johnson’s exclusionary contracts and other anti-competitive practices have denied U.S. patients access to therapeutic options and undermined the benefits of “robust” price competition in the “innovative and growing” biologics marketplace for patients.

The Record Network